Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Signori

Showing results (141-150 of 296) with videos related to

Pageof 30
Sort By:
Blood Reviews|May 9, 2026
Clostridioides difficile infection in non-transplanted adults with haematological malignancy: Systematic review and meta-analysis on behalf of European Conference on Infections in Leukemia (ECIL) and Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT)Chiara Oltolini, Agnieszka Piekarska, Alessio Signori, et al.
AIDS (London, England)|February 7, 2014
Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patientsChiara Dentone, Antonio Di Biagio, Alessia Parodi, et al.
Frontiers in Neurology|March 27, 2023
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbiditiesCaterina Lapucci, Francesco Tazza, Silvia Rebella, et al.
Brain : a Journal of Neurology|November 30, 2020
Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosisSimona Schiavi, Maria Petracca, Peng Sun, et al.
Frontiers in Medicine|March 1, 2021
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical PerspectiveDaniele Roberto Giacobbe, Alessio Signori, Filippo Del Puente, et al.
CNS Drugs|December 11, 2021
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational StudySerena Palmeri, Marta Ponzano, Federico Ivaldi, et al.
Ebiomedicine|June 24, 2025
Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trialsNoemi Montobbio, Francesca Bovis, Alessio Signori, et al.
Headache|January 21, 2025
The "central vein sign" to differentiate multiple sclerosis from migraineGiulia Silvestri, Luca Roccatagliata, Francesco Tazza, et al.
Journal of Medical Virology|July 22, 2014
The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapyAntonio Di Biagio, Stefano Rusconi, Angela Marzocchetti, et al.
International Journal of Antimicrobial Agents|August 28, 2016
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglyceridesAntonio Di Biagio, Niccolò Riccardi, Lucia Taramasso, et al.
Pageof 30

Showing results (141-150 of 296) with videos related to

Sort By:
Pageof 30
Blood Reviews|May 9, 2026
Clostridioides difficile infection in non-transplanted adults with haematological malignancy: Systematic review and meta-analysis on behalf of European Conference on Infections in Leukemia (ECIL) and Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT)Chiara Oltolini, Agnieszka Piekarska, Alessio Signori, et al.
AIDS (London, England)|February 7, 2014
Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patientsChiara Dentone, Antonio Di Biagio, Alessia Parodi, et al.
Frontiers in Neurology|March 27, 2023
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbiditiesCaterina Lapucci, Francesco Tazza, Silvia Rebella, et al.
Brain : a Journal of Neurology|November 30, 2020
Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosisSimona Schiavi, Maria Petracca, Peng Sun, et al.
Frontiers in Medicine|March 1, 2021
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical PerspectiveDaniele Roberto Giacobbe, Alessio Signori, Filippo Del Puente, et al.
CNS Drugs|December 11, 2021
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational StudySerena Palmeri, Marta Ponzano, Federico Ivaldi, et al.
Ebiomedicine|June 24, 2025
Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trialsNoemi Montobbio, Francesca Bovis, Alessio Signori, et al.
Headache|January 21, 2025
The "central vein sign" to differentiate multiple sclerosis from migraineGiulia Silvestri, Luca Roccatagliata, Francesco Tazza, et al.
Journal of Medical Virology|July 22, 2014
The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapyAntonio Di Biagio, Stefano Rusconi, Angela Marzocchetti, et al.
International Journal of Antimicrobial Agents|August 28, 2016
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglyceridesAntonio Di Biagio, Niccolò Riccardi, Lucia Taramasso, et al.
Pageof 30